TNFSF10 and neoplasm: Another TRAIL derivative, Circularly Permuted Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (CPT), also known as aponermin, demonstrated moderate anti-tumor activity in a xenograft model even after multiple large doses, and required being given in combination with a chemotherapeutic agent to achieve a more pronounced effect [23].